Cansino Biologics, Inc. Class ASSE: 688185

Voluntary Disclosure on the Approval of Clinical Trial for Recombinant Polio Vaccine in Indonesia

· Issued by Cansino Biologics, Inc. Class A via Shanghai Stock Exchange
Voluntary Disclosure on the Approval of Clinical Trial for Recombinant Polio Vaccine in Indonesia

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment